权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Studies towards a pan-genome and genetic manipulation of Clostridium scindens

梭菌的全基因组和遗传操作研究

基本信息

批准号：
9979542
负责人：
Jason Michael Ridlon
金额：
$ 7.52万
依托单位：
UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
起止时间：
2020-02-24 至 2022-01-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9979542
关键词：
Adenine Adoptive Transfer Anaerobic Bacteria Animal Model Anion Exchange Resins Antibiotics Bacteria Bile Acids Binding Biology Cecum Cholestyramine Cholic Acids Clostridium Clostridium difficile Collection Conserved Sequence DNA DNA Restriction-Modification Enzymes Data Deoxycholic Acid Development Diarrhea Digestion Disease Etiology Feces Firmicutes Future Gastrointestinal tract structure Generations Genes Genetic Genetic Recombination Genome Germination Growth Health Human Infection Intestinal Content Malignant neoplasm of gastrointestinal tract Mediating Medical Methods Methylation Modification Molecular Biology Mus Operon Patients Peptide Antibiotics Personal Communication Phylogeny Physiology Plasmids Probability Regulon Reporting Reproduction spores Research Research Personnel Resistance Role Secondary to System Taurocholic Acid Testing Variant Virulence Work bile acid metabolism cell growth comparative genomics differential expression dysbiosis experimental study functional genomics genetic manipulation genome sequencing gut bacteria host-microbe interactions in vivo methylome mouse model mutant nanopore pan-genome prevent response screening transcriptome transcriptome sequencing transcriptomics whole genome

项目摘要

Project Summary Recent studies suggest that Clostridium scindens is protective against C. difficile infection in vivo. Antibiotic- induced dysbiosis results in altered bile acid profile which is thought to allow C. difficile to grow and cause infection. Prior studies have shown that host bile acids such as taurocholic acid induce C. difficile spore germination in the GI tract; whereas conversion of host bile acids to secondary bile acids such as deoxycholic acid (DCA) by C. scindens prevents C. difficile spore germination and vegetative cell growth. However, a genetic system is currently lacking in C. scindens, representing a barrier to demonstrating causation with respect to DCA formation and inhibition of C. difficile growth and virulence. We have a collection of over a dozen strains of C. scindens strains whose genome sequences are not known. In Aim 1, we propose to sequence the complete genomes of these strains. We have already completed the genome/methylome of C. scindens ATCC 35704T. Determining the ‘pan-genome’ of C. scindens will allow determination of strain variation, and may allow identification of strains more susceptible to genetic manipulation. We will also perform transcriptomic analysis with two C. scindens strains in a newly developed defined medium and identify genes differentially expressed in the presence of bile acids. In Aim 2 we test the hypothesis that the barrier to genetic manipulation of C. scindens is restriction modification (FM) systems. Methylome data has identified extensive m6A modification among conserved sequences in the genome. We will utilize a plasmid artificial modification (PAM) approach to developing a pyrE counter-selectable marker. These studies will provide substantial progress in the understanding of Clostridium scindens biology, bile acid metabolism, and significant progress towards genetic manipulation of C. scindens. This will allow future proposals aimed at testing the hypothesis that DCA formation by C. scindens protects against C. difficile infection in vivo.

项目总结